Header Logo

Connection

KAREN RABIN to Etoposide

Back to Details
This is a "connection" page, showing publications KAREN RABIN has written about Etoposide.
KAREN RABIN
Connection Strength
0.038
Etoposide
  1. Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG. Haematologica. 2019 05; 104(5):986-992.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.